|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006813,
umls-concept:C0013090,
umls-concept:C0014806,
umls-concept:C0080194,
umls-concept:C0205409,
umls-concept:C0441655,
umls-concept:C0681850,
umls-concept:C0907410,
umls-concept:C0949665,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C1711254,
umls-concept:C2349001,
umls-concept:C2697811
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-2-23
|
|
pubmed:abstractText |
The in vitro susceptibilities of 478 Campylobacter jejuni and Campylobacter coli strains isolated from Finnish subjects during 2002 to 2004 were determined. Susceptibility to erythromycin remained high, and telithromycin did not offer any advantage over erythromycin. Reduced susceptibilities to fluoroquinolones and doxycycline were detected almost exclusively among isolates of foreign origin.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-10332013,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-11087163,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-11266291,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-11481294,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-12499176,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-14613954,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-14718099,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-15207057,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-15256027,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-1759828,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-2055811,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-7695284,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-7810993,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-9301992,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-9333055,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-9502453,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16495275-9670357
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1086-8
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects.
|
|
pubmed:affiliation |
Department of Bacteriology and Immunology, Haartman Institute, P.O. Box 21, FIN-00014 University of Helsinki, Helsinki, Finland.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
